Young children in sub-Saharan Africa and South Asia who become sick or malnourished continue to have a high risk of death in the six months after being hospitalized, according to findings by researchers in the Childhood Acute Illness & Nutrition (CHAIN) Network. Appearing in The Lancet Global Health, the study of 3,101 acutely ill children […]

Monitoring and Evaluation helps us keep track of our public engagement activities and outcomes. KEMRI -Wellcome Trust recently completed a report detailing our experiences and learning. Find the report here: Community and Public Engagement M&E Report

Results from a clinical trial completed in Kenya have determined that a safe dose of the antibiotic, fosfomycin, can be used to treat babies with neonatal sepsis. This is a significant development, as there are very few antibiotics specifically licensed to treat multidrug-resistant infections in babies. The NeoFosfo trial investigated the pharmacokinetics (PK) and safety […]

Read more here: Issue brief 30th June 2022

Maternal mortality is still unacceptably high in Kenya. A recently published policy brief examines the implementation of the Linda Mama free maternity program in Kenya. The process evaluation of the Linda Mama program reveals that there are barriers in access to maternal care, inefficiencies in the funding flow, claims process and reimbursement processes, and gaps […]

Mainga Hamaluba, Head of Clinical Research at the KEMRI-Wellcome Trust Research Programme in Kenya, will develop a pragmatic adaptive trial platform to evaluate key interventions for improving child survival in East Africa in real-life routine practice conditions as a faster and lower-cost alternative to traditional randomized controlled trials. Dr. Hamaluba has led a wide-range of […]

Tittle: Social, Ethical and Regulatory implications of conducting a malaria Vaccine Efficacy trial in a human infection study in Kenya. Duration: 36 months Background Malaria remains an important public health problem in many LMICs, including Kenya – necessitating alternative prevention and control strategies. Malaria human infection studies (HIS) – trials that involve the deliberate infection […]

Please join KEMRI-Wellcome and Harvard University for a special 2-day webinar on focused on thematic topics stemming from the “Rethinking Malaria in the Context of COVID–19” global engagement—Malaria Governance, Integrated Service Delivery, Training & Capacity Building for Malaria on September 28–29, 2021 from 9AM–11:30AM EDT | 4PM–6:30PM EAT. In keeping with a longstanding academic tradition, and in partnership with a committed network of co-sponsors, we have assembled a diverse group […]

Congratulations to Professor George Warimwe on being awarded the Royal Society Africa Prize winner 2021! Prof. Warimwe was  awarded for his work on zoonoses vaccine development, capacity building in Africa, and his innovative research proposal. The Royal Society Africa Prize is to recognize research scientists based in Africa who are making an innovative contribution to […]

Results from the first major genomic epidemiology of SARS-CoV-2 infections in Kenya were published today in the esteemed Nature Communications (DOI:10.1038/s41467-021-25137-x) peer-reviewed journal. The work carried by a team of scientist at the KEMRI-Wellcome Trust Research Programme and the Ministry of Health, examined cases during the early phase of the epidemic (March – July 2020). Out of […]